Halyard Health, Inc. (HYH) Shares Bought by Dimensional Fund Advisors LP
Dimensional Fund Advisors LP boosted its holdings in Halyard Health, Inc. (NYSE:HYH) by 19.3% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 3,133,049 shares of the medical instruments supplier’s stock after purchasing an additional 507,893 shares during the quarter. Dimensional Fund Advisors LP owned about 6.70% of Halyard Health worth $123,067,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also made changes to their positions in HYH. Meadow Creek Investment Management LLC boosted its holdings in shares of Halyard Health by 1.1% in the first quarter. Meadow Creek Investment Management LLC now owns 2,660 shares of the medical instruments supplier’s stock valued at $101,000 after acquiring an additional 28 shares during the period. Riverhead Capital Management LLC boosted its holdings in shares of Halyard Health by 88.1% in the second quarter. Riverhead Capital Management LLC now owns 3,197 shares of the medical instruments supplier’s stock valued at $126,000 after acquiring an additional 1,497 shares during the period. Victory Capital Management Inc. acquired a new stake in shares of Halyard Health in the first quarter valued at approximately $153,000. LS Investment Advisors LLC boosted its holdings in shares of Halyard Health by 16.1% in the second quarter. LS Investment Advisors LLC now owns 4,017 shares of the medical instruments supplier’s stock valued at $158,000 after acquiring an additional 556 shares during the period. Finally, Tower Research Capital LLC TRC boosted its holdings in shares of Halyard Health by 102.5% in the first quarter. Tower Research Capital LLC TRC now owns 4,836 shares of the medical instruments supplier’s stock valued at $184,000 after acquiring an additional 2,448 shares during the period. 91.02% of the stock is owned by hedge funds and other institutional investors.
Several equities research analysts have recently weighed in on HYH shares. TheStreet raised Halyard Health from a “c” rating to a “b” rating in a report on Thursday, June 22nd. BidaskClub raised Halyard Health from a “hold” rating to a “buy” rating in a report on Wednesday, June 28th. Zacks Investment Research raised Halyard Health from a “hold” rating to a “buy” rating and set a $44.00 price objective for the company in a report on Wednesday, July 12th. Stephens raised Halyard Health from an “equal weight” rating to an “overweight” rating in a report on Thursday, August 3rd. Finally, Deutsche Bank AG increased their price objective on Halyard Health from $35.00 to $42.00 and gave the company a “buy” rating in a report on Thursday, August 3rd. One analyst has rated the stock with a hold rating and five have issued a buy rating to the stock. The stock has an average rating of “Buy” and an average price target of $42.25.
TRADEMARK VIOLATION WARNING: This piece of content was originally posted by Watch List News and is owned by of Watch List News. If you are reading this piece of content on another website, it was copied illegally and republished in violation of international copyright and trademark legislation. The original version of this piece of content can be accessed at https://www.watchlistnews.com/halyard-health-inc-hyh-shares-bought-by-dimensional-fund-advisors-lp/1600728.html.
Shares of Halyard Health, Inc. (NYSE:HYH) opened at 45.03 on Friday. The stock has a 50 day moving average price of $43.72 and a 200 day moving average price of $39.69. The firm has a market capitalization of $2.10 billion, a P/E ratio of 43.30 and a beta of 1.76. Halyard Health, Inc. has a 12-month low of $31.59 and a 12-month high of $46.36.
Halyard Health (NYSE:HYH) last issued its quarterly earnings results on Wednesday, August 2nd. The medical instruments supplier reported $0.51 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.37 by $0.14. Halyard Health had a return on equity of 8.29% and a net margin of 3.06%. The business had revenue of $399.20 million during the quarter, compared to the consensus estimate of $399.16 million. During the same period in the previous year, the business earned $0.45 EPS. The business’s quarterly revenue was down .2% on a year-over-year basis. Equities analysts anticipate that Halyard Health, Inc. will post $1.96 earnings per share for the current fiscal year.
Halyard Health Profile
Halyard Health, Inc is a medical technology company. The Company operates through two segments: Medical Devices and Surgical and Infection Prevention (S&IP). The Medical Devices segment provides a portfolio of product offerings focused on pain management, respiratory and digestive health. The S&IP segment provides healthcare supplies and solutions that target the prevention of healthcare-associated infections.
Want to see what other hedge funds are holding HYH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Halyard Health, Inc. (NYSE:HYH).
Receive News & Ratings for Halyard Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Halyard Health Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.